Minireviews Open Access
Copyright ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Oct 27, 2018; 10(10): 695-701
Published online Oct 27, 2018. doi: 10.4254/wjh.v10.i10.695
Anthropometric indicators of visceral adiposity as predictors of non-alcoholic fatty liver disease: A review
Naiade Silveira Almeida, Raquel Rocha, Carla Daltro, Department of Sciences of Nutrition, School of Nutrition, Universidade Federal da Bahia, Salvador 40110-150, Bahia, Brazil
Helma Pinchemel Cotrim, Faculty of Medicine of Bahia, Universidade Federal da Bahia, Salvador 40110-150, Bahia, Brazil
ORCID number: Naiade Silveira Almeida (0000-0001-7193-3666); Raquel Rocha (0000-0002-2687-2080); Helma Pinchemel Cotrim (0000-0001-7698-6919); Carla Daltro (0000-0003-1115-688X).
Author contributions: All authors equally contributed to this paper with conception, literature review, drafting and critical revision, editing, and approval of the final version.
Conflict-of-interest statement: No potential conflicts of interest. No financial support.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Raquel Rocha, DSc, MSc, Adjunct Professor, Department of Sciences of Nutrition, School of Nutrition, Universidade Federal da Bahia, Avenida Araújo Pinho, 32, Salvador 40110-150, Bahia, Brazil. raquelrocha2@yahoo.com.br
Telephone: +55-71-32837721 Fax: +55-71-32837721
Received: March 30, 2018
Peer-review started: March 30, 2018
First decision: April 26, 2018
Revised: June 1, 2018
Accepted: June 8, 2018
Article in press: June 9, 2018
Published online: October 27, 2018
Processing time: 211 Days and 11.5 Hours

Abstract

The objective was to critically analyze studies that evaluated the predictive capacity of indicators of visceral adiposity in non-alcoholic fatty liver disease (NAFLD). The bibliographic research was carried out using the electronic database PubMed, LILACS and SciELO, references of selected articles. Although we found few studies, they have already used several indicators of visceral adiposity as waist circumference, waist-to-hip ratio, waist-to-height ratio, Lipid accumulation product, Body Shape Index, Body Roundness Index and most them were good predictors of NAFLD. Thus, the anthropometric indicators may contribute for the diagnosis of NAFLD in a simple, low-cost and non-invasive way, allowing early therapeutic measures to prevent the evolution to non-alcoholic steatohepatitis.

Key Words: Anthropometry; Adiposity; Non-alcoholic fatty liver disease; Abdominal fat; Pediatrics; Predictive value

Core tip: Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide and presents evolutional potential for more severe forms of the disease such as cirrhosis and hepatocellular carcinoma. The most effective treatment is based on changes in lifestyle, diet and exercise; however, this presents the challenge of having to be performed for a long time. The diagnosis, especially of non-alcoholic steatohepatitis (NASH), requires invasive examination such as liver biopsy. The anthropometric clinical indicators of visceral obesity, of easy applicability and low cost, have been very promising in the prediction of NAFLD. Thus, future studies could be conducted to use them in the prediction of NASH, besides assisting in the therapeutic and preventive conduction NASH.



INTRODUCTION

Non-alcoholic fatty liver disease (NAFLD) is a relevant metabolic disorder with a high evolutional potential, including from isolated hepatic steatosis to non-alcoholic steatohepatitis (NASH), and if left untreated, can progress to fibrosis, cirrhosis and even liver failure[1].

Excess weight, mainly the accumulation of visceral fat, is considered the main risk factor for NAFLD, being closely related to the severity of the disease[2-4]. Currently, clinical anthropometric indicators such as waist-to-height ratio (WHtR) and lipid accumulation product (LAP) are described in the literature as the most sensitive and specific for discriminating visceral fat compared to the classic parameters as waist circumference (WC) and body mass index (BMI)[5].

Some formulas recommended in the literature for NAFLD prediction already use anthropometric indicators such as BMI and WC[6,7]. However, there are few studies that have evaluated predictive capacity as well as the cutoff points of these new indicators in individuals with NAFLD[8-11]. This review aimed to critically analyze studies that assessed the ability of anthropometric indicators of adiposity to predict NAFLD.

LITERATURE SEARCH

To perform the search and retrieval of scientific articles, we used the PubMed (National Library of Medicine), Scielo (Scientific Eletronic Library Online) and LILACS (Literatura Latino-Americana e do Caribe em Ciências da Saúde) databases. The “OR” and “AND” connectors were used to combine the descriptors: (“non-alcoholic fatty liver disease” or “non-alcoholic steatohepatitis” or “fatty liver” or “NAFLD”) and (“adult”) and (“waist circumference” or “body mass index” or “waist-to-height ratio” or “conicity index” or “lipid accumulation product”) and (“discriminatory performance” or “optimal cutoff points”). The articles of interest listed in the references have also been identified and reviewed.

Inclusion criteria were: the availability of the full text in the database; publication in the last ten years (Feb 2008-Feb 2018); written in Portuguese, English or Spanish. Exclusion criteria were: review studies, repeated studies in more than one database, research outside the previously determined context.

After analyzing the titles and abstracts, according to the eligibility criteria, the studies were selected for reading in full. One thousand eight hundred and sixty-three studies were found in the databases. After completing the selection of the studies based on the reading of the titles and abstracts, 1858 studies were excluded: 1845 did not meet the eligibility criteria; 1 duplicated, 1 Chinese, 1 cohort study; 1 evaluated individuals with hepatitis B and C virus, and 2 studies were included after the screening of the references.

Thus, eleven articles were included in the review. The main information of the studies as authorship and year of publication, where the study was conducted, the study population characteristics (number of individuals and age), anthropometric indicators evaluated BMI, WC, WHtR, LAP, Waist-To-Hip Ratio (WHR), Body Shape Index (ABSI), Body Roundness Index (BRI) and diagnosis criteria of NAFLD (Table 1).

Table 1 Studies evaluating the anthropometric indicators as predictors of non-alcoholic fatty liver disease.
Ref.CountryPopulation (n)Age (yr)Anthropometric indicatorNAFLD diagnosis
Yoo et al[14]South KoreaNAFLD (77)20-88WC and WHtRTomography
Non-NAFLD (379)
Zheng et al[9]ChinaNAFLD (250)36.6 ± 11.1WHR, BMI, WC and WHtRLiver biopsy
Non-NAFLD (240)37.3 ± 10.2
Ju et al[10]South KoreaNAFLD (2553)42.5 ± 5.1BMI and WCUltrasonography
Non-NAFLD (6606)41.6 ± 4.9
Cuthbertson et al[8]England and GermanyNAFLD (168)50.3 ± 11.9LAPProton magnetic resonance spectroscopy
Non-NAFLD (168)48.6 ± 10.9
Monteiro et al[16]BrazilObese with NAFLD (45)11-17WCUltrasonography
Obese without NAFLD (100)
Zhang et al[17]ChinaNAFLD (362)7-18WHtR, BMI and WCUltrasonography
Non-NAFLD (6867)
Motamed et al[11]IranNAFLD (2048)48.6 ± 12.7WHtR, WHR, ABSI, BRIUltrasonography
Non-NAFLD (2824)39.0 ± 15.4
Özhan et al[18]TurkeyObese without NAFLD (130)11.6 ± 2.7WHtRUltrasonography
Obese with NAFLD (202)12.1 ± 2.6
Lin et al[19]TaiwanNAFLD (167)18.8 ± 1.9WHtR, WHRUltrasonography
Non-NAFLD (1043)15.1 ± 2.8
Lee et al[15]United StatesBlack (94) and White (58)14.7 ± 1.8WCProton magnetic resonance spectroscopy
overweight and obese adolescents14.5 ± 1.5
Dai et al[20]ChinaNAFLD (12150)18-94LAPUltrasonography
Non-NAFLD (28309)
CLINICAL ANTHROPOMETRIC INDICATORS OF VISCERAL ADIPOSITY

Classical anthropometric indicators, such as BMI and WC, are disseminated in clinical practice to assess nutritional status, since they are relatively simple and inexpensive tools[12,13]. Visceral obesity is the most important risk factor for NAFLD[2-4] and recent studies have been investigating the relevance of WC and other new clinical indicators of visceral adiposity (WHtR and LAP) in NAFLD diagnosis (Table 2).

Table 2 Cut-offs and areas under the ROC curve, sensitivity and specificity of anthropometric indicators to determine non-alcoholic fatty liver disease.
Ref.IndicatorTotal
Women
Men
AUC (95%CI)Cut-offs pointSens (%)Spec (%)AUC (95%CI)Cut-offs pointSens (%)Spec (%)AUC (95%CI)Cut-offs pointSens (%)Spec (%)
Yoo et al[14]WHtR0.80 (0.74-0.86)0.5390630.72 (0.63-0.81)0.527165
WC0.79 (0.73-0.86)8484620.74 (0.65-0.83)897564
Zheng et al[9]WHR0.916 (0.86-0.97)0.899966
BMI0.854 (0.78-0.93)24.229664
WC0.876 (0.81-0.94)82.59568
WHtR0.878 (0.82-0.94)0.499664
Ju et al[10]WC0.821 (0.801-0.840)80.3950.759 (0.746-0.773)84.945
BMI0.83 (0.811-0.850)22.7150.76 (0.747-0.773)24.465
Cuthbertson et al[8]LAP0.78 (0.73-0.83)0.77 (0.69-0.85)0.74 (0.66-0.82)
Monteiro et al[16]WC0.72 (0.636-0.804)66.7640.7330.7040.5670.6
Zhang et al[17]WHtR0.95 (0.94-0.96)0.4785.292.5
WC0.94 (0.92-0.95)80186.287.4
BMI0.93 (0.91-0.94)80186.287.6
Motamed et al[11]WHtR0.8566 (0.8419-0.8714)0.5883.371.70.8457 (0.8320-0.8593)0.53382.770.8
BRI0.8566 (0.8419-0.8714)583.371.70.8457 (0.8320-0.8593)482.770.8
WHR0.7673 (0.7487-0.7860)0.8018 (0.7862-0.8173)
ABSI0.6598 (0.6382-0.6814)0.6539 (0.6351-0.6727)
Özhan et al[18]WHtR0.6248.473.8
Lin et al[19]WHtR0.80 (0.76-0.83)0.46970.176.9
WHR0.755 (0.714-0.795)
1Lee et al[15]WC0.847101.59380
Dai et al[20]LAP0.887 (0.882-0.892)2382790.843 (0.837-0.849)30.57775

In the studies selected here it is observed that different methods were used to identify hepatic steatosis: liver biopsy[9], computed tomography[14], proton magnetic resonance spectroscopy[8,15] being that the great majority realized abdominal ultrasonography[10,11,16-20].

Most of these methods such as ultrasonography, computed tomography and magnetic resonance imaging are important in the diagnosis of NAFLD, however these techniques cannot distinguish benign steatosis from steatohepatitis, severity of inflammation and grade and degree of fibrosis or stage of disease[21]. The liver biopsy, although not used in routine clinical practice remains the only available procedure to grade and to stage NAFLD and to exclude other causes of liver disease. It has been considered a gold standard method[22].

WAIST CIRCUMFERENCE

The WC is an anthropometric indicator widely used in population studies and in clinical practice to assess central obesity, better reflecting the content of visceral fat, in addition to having a good relationship with total body fat[14,23]. However, it presents important limitations when used alone as a predictor of visceral fat[24].

WC and BMI indicators are widely used in the evaluation of individuals with NAFLD[2,8,25]. However, it is known BMI limitations in the evaluation of the composition and distribution of body fat, considering that this indicator only evaluates total body mass[26]. In most studies, the WC was assessed by WHO[26] (midpoint between the iliac crest and the last rib)[9,14,17]. Only Ju et al[10] performed the measurement of WC in the umbilical line. Yoo et al[14], in an observational cohort study, investigated the WC in 456 adults and elderly Koreans, with BMI of 26.5 ± 2.5 kg/m2 in men NAFLD group and 27.3 ± 3.3 kg/m2 in women NAFLD group and found a cutoff point of 89.0 cm for men and 84.0 cm for women, with sensitivity above 74%, in the prediction of NAFLD. Ju et al[10] investigated the WC in 9159 adults Koreans in a cross-sectional study with BMI of 22.4 ± 2.5 kg/m2 in Non-NAFLD group and 25.6 ± 2.61 kg/m2 in NAFLD group and identified with better levels of sensitivity and specificity, the WC cutoff of 84.9 cm for men and 80.4 cm for women. They observed that WC and BMI showed similar predictive capacity in both sexes, showing that there is still controversy about the best anthropometric parameter to predict NAFLD. In the study conducted by Zheng et al[9] in a cross-sectional study with 490 patients Chinese, between 15-56 years, which included 96 patients with liver disease, 86 hepatitis, 19 hepatic hemangioma, and 39 autoimmune liver disease, with BMI 24.8 ± 10.1 kg/m2 in Non-NAFLD group and 36.8 ± 10.1 kg/m2 in NAFLD group, BMI and WC had AUC above 0.84 in the total sample.

In children, the WC AUC was 0.94, with the cutoff point at the 80th percentile for age, in the study by Zhang et al[17], a cross sectional study with 7229 students in China. Lee et al[15] evaluated white and black obese adolescents in the United States and found an optimal WC cutoff point for predicting NAFLD of 101.5 cm, AUC: 0.847, 93% sensitivity and 80% specificity in white obese women, and with no statistical difference between the values found between the blacks. The cross-sectional study by Monteiro et al[16], which evaluated 145 obese children and adolescents in Brazil, found higher WC (AUC: 0.720) when compared to trunk fat mass (AUC: 0.661), estimated by Dual-energy X-ray absorptiometry, however lower than the intra-abdominal adipose tissue (AUC: 0.741), measured by ultrasound examination. It should be noted that the authors did not present the cut-off points of the indicators. It is observed that most of these studies were developed in Asian populations[9,14,17], considering that WC cutoff points may differing between racial and ethnic groups more studies are needed for this identification.

WAIST-TO-HIP RATIO

The Waist-To-Hip Ratio (WHR) is determined by dividing the waist circumference by the circumference of the hip. This indicator is used to characterize how body fat is distributed, if it is concentrated in the central region or in body extremities. Sometimes the gain or loss of weight causes similar alterations in waist and hip circumferences, without altering the final ratio, so in these cases, WHR is not so useful to evaluate body mass changes[27].

Few studies have evaluated the WHR in predicting NAFLD. However, the WHR was the indicator with the highest predictive capacity (AUC: 0.91) for NAFLD in the study by Zheng et al[9], as a cutoff point of 0.89 for the total sample. Motamed et al[11], in a cross-sectional study with Iranian adults, reported an AUC above 0.70 of the WHR in both sexes to predict NAFLD, but cut points were not presented. Despite the limited amount of studies found in the literature that addressed the predictive capacity of WHR in NAFLD, the results found in both studies show that this indicator can be considered as a good predictor of NAFLD.

WAIST-TO-HEIGHT RATIO

The WHtR is an indicator of abdominal obesity that has been used in several studies to evaluate metabolic disorders[28-30]. The analysis of the WHtR suggests that a person WC should not exceed half the height value, presenting a better sensitivity in the evaluation of the health risk when compared to the measurement of isolated WC in different populations[31].

Yoo et al[14], Zheng et al[9] and Motamed et al[11] reported an AUC above 0.71 of the WHtR to detect NAFLD. Yoo et al[14] identified cutoff points of 0.53 (sens: sensitivity 90%, spec: specificity 63%) for women and 0.52 (sens: 71%, spec: 65%) for men. The cutoff points found in the study conducted by Motamed et al[11] with Iranians were similar for men 0.533 (sens: 82.7%, spec: 70.8%), but not for women which was 0.580 (sens: 83.3%, spec: 71.7%). Already Zheng et al[9] did not stratify the results by sex.

In children, the WHtR was the indicator that presented the highest AUC 0.95 and with cutoff points of 0.47 (sens: 95%, spec: 96%) in Zhang et al[17]. Lin et al[19] evaluated 1210 children aged 10-19 years in Taiwan and identified that WHtR had AUC higher than that of WHR. The cutoff point of WHtR to predict NAFLD in the study population was 0.499 (sens: 70.1%, spec: 76.9%). Özhan et al[18], evaluated 332 obese children with and without NAFLD, and the WHtR presented an optimal cutoff point for the prediction of NAFLD of 0.62, but with low sensitivity (48.5%) and high specificity (73.8%). In all this study WC was measured according to WHO[26].

In adults, the advantage of this indicator is related to the ability to neutralize the differences between the heights, allowing to individualize the interpretation of the fat concentration for different ages, since only a change in the value of the indicator occurs if the modification comes from the WC. In addition to be a low-cost indicator, it uses traditional and simple body measurements, and is a non-invasive method, being easily interpreted and reproducible[29,30].

LIPID ACCUMULATION PRODUCT

LAP is a proposed indicator for estimating lipid concentration in adults. Its formula includes data from WC and the serum concentration of triglycerides in the fasted state. The indicator proposes to investigate if the concentration of lipids exerts effect in the evaluation of the cardiovascular risks, better than the BMI[32].

Only two studies used LAP in the prediction of NAFLD[8,20]. Cuthbertson et al[8] evaluated 4 cohorts in Germany and England and although it has demonstrated an AUC of 0.78, the authors did not calculate cutoff points for NAFLD. Already a large cross-sectional study[20] that evaluated 40459 Chinese, the LAP showed high accuracy for diagnosing NAFLD in both men and women (AUC 0.843 and 0.887, respectively), with cutoff points of 30.5 (sens: 77%, spec: 75%) and 23.0 (sens: 82%, spec: 79%), respectively, and especially in the younger population between 18 and 44 years old.

Therefore, further studies are needed to confirm its usefulness in predicting this condition in other population groups since it is an excellent predictor of NAFLD in the Asian population. In addition, it is important to highlight a limitation in the clinical practice of this indicator, which requires application of complex formula and serum triglyceride values[33].

OTHER INDICATORS

Two new indicators of obesity, Ody Shape Index (ABSI) e Body Roundness Index (BRI) were described in literature. The ABSI was proposed by Krakauer et al[34] and it is calculated with the values of WC, BMI and height. Their analysis suggests that the ABSI allows to evaluate the excess risk of high WC. And Thomas et al[35] developed BRI to predict body fat and percentage of visceral adipose tissue, calculated with WC and height data.

Motamed et al[11] evaluated the ability of two new obesity indicators to predict NAFLD. In this study BRI and WHtR presented the same discriminatory power (AUC above 0.84) for NAFLD. However, ABSI was not a good indicator to predict NAFLD. Because BRI is an indicator of obesity that is still recent and little studied, the use in clinical practice to assess the discriminatory capacity of NAFLD deserves caution.

Of all the articles studied only one study, Ju et al[10], stratified the population in NAFLD and NASH. However, this study did not evaluate the predictive capacity of these indicators in NASH, only in NAFLD, besides NASH classification was evaluated by the presence of steatosis associated with elevation of alanine aminotransferase. Therefore, these studies that investigated the anthropometric indicators of visceral adiposity can only predict NAFLD. In addition, we can highlight in these studies the predictive capacity of the anthropometric clinical indicators for NAFLD that the main limitations were the different diagnostic methods used to detect NAFLD, the different ethnicities and different age groups, such as the inclusion of the elderly in some samples.

CONCLUSION

There are still few studies that evaluated anthropometric indicators of visceral obesity in the prediction of NAFLD, and these already have promising results. The identification of these indicators, with specific cutoff points considering the ethnic and racial groups, for use in the prediction of NAFLD, and especially NASH, may help in the early diagnosis, allowing a therapeutic and preventive approach to this population.

Footnotes

Manuscript source: Invited manuscript

Specialty type: Gastroenterology and hepatology

Country of origin: Brazil

Peer-review report classification

Grade A (Excellent): 0

Grade B (Very good): 0

Grade C (Good): C, C, C, C

Grade D (Fair): 0

Grade E (Poor): 0

P- Reviewer: Marzuillo P, Streba LLAM, Tzamaloukas AH, Tzamaloukas AHH S- Editor: Ji FF L- Editor: A E- Editor: Song H

References
1.  Gastaldelli A. Fatty liver disease: the hepatic manifestation of metabolic syndrome. Hypertens Res. 2010;33:546-547.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 27]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
2.  Rocha R, Cotrim HP, Carvalho FM, Siqueira AC, Braga H, Freitas LA. Body mass index and waist circumference in non-alcoholic fatty liver disease. J Hum Nutr Diet. 2005;18:365-370.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 62]  [Cited by in F6Publishing: 60]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
3.  Eguchi Y, Eguchi T, Mizuta T, Ide Y, Yasutake T, Iwakiri R, Hisatomi A, Ozaki I, Yamamoto K, Kitajima Y. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol. 2006;41:462-469.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 211]  [Cited by in F6Publishing: 218]  [Article Influence: 12.1]  [Reference Citation Analysis (0)]
4.  van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, London R, Peduto T, Chisholm DJ, George J. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48:449-457.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 411]  [Cited by in F6Publishing: 435]  [Article Influence: 27.2]  [Reference Citation Analysis (0)]
5.  Roriz AK, Passos LC, de Oliveira CC, Eickemberg M, Moreira Pde A, Sampaio LR. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS One. 2014;9:e103499.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 63]  [Cited by in F6Publishing: 78]  [Article Influence: 7.8]  [Reference Citation Analysis (0)]
6.  Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1238]  [Cited by in F6Publishing: 1742]  [Article Influence: 96.8]  [Reference Citation Analysis (0)]
7.  Wang J, Xu C, Xun Y, Lu Z, Shi J, Yu C, Li Y. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population. Sci Rep. 2015;5:16494.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 46]  [Cited by in F6Publishing: 77]  [Article Influence: 8.6]  [Reference Citation Analysis (0)]
8.  Cuthbertson DJ, Weickert MO, Lythgoe D, Sprung VS, Dobson R, Shoajee-Moradie F, Umpleby M, Pfeiffer AF, Thomas EL, Bell JD. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. Eur J Endocrinol. 2014;171:561-569.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 100]  [Cited by in F6Publishing: 118]  [Article Influence: 11.8]  [Reference Citation Analysis (0)]
9.  Zheng RD, Chen ZR, Chen JN, Lu YH, Chen J. Role of Body Mass Index, Waist-to-Height and Waist-to-Hip Ratio in Prediction of Nonalcoholic Fatty Liver Disease. Gastroenterol Res Pract. 2012;2012:362147.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 48]  [Cited by in F6Publishing: 60]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
10.  Ju DY, Choe YG, Cho YK, Shin DS, Yoo SH, Yim SH, Lee JY, Park JH, Kim HJ, Park DI. The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults. Clin Mol Hepatol. 2013;19:140-147.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 20]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
11.  Motamed N, Rabiee B, Hemasi GR, Ajdarkosh H, Khonsari MR, Maadi M, Keyvani H, Zamani F. Body Roundness Index and Waist-to-Height Ratio are Strongly Associated With Non-Alcoholic Fatty Liver Disease: A Population-Based Study. Hepat Mon. 2016;16:e39575.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 32]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
12.  Tonding SF, Silva FM, Antonio JP, Azevedo MJ, Canani LH, Almeida JC. Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus. Nutr J. 2014;13:124.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 13]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
13.  Veena J, Muragundla A, Sidgiddi S, Subramaniam S. Non-alcoholic fatty liver disease: need for a balanced nutritional source. Br J Nutr. 2014;112:1858-1872.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 28]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
14.  Yoo HJ, Park MS, Lee CH, Yang SJ, Kim TN, Lim KI, Kang HJ, Song W, Yeon JE, Baik SH. Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians. Liver Int. 2010;30:1189-1196.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 40]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
15.  Lee S, Kuk JL, Boesch C, Arslanian S. Waist circumference is associated with liver fat in black and white adolescents. Appl Physiol Nutr Metab. 2017;42:829-833.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 10]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
16.  Monteiro PA, Antunes Bde M, Silveira LS, Christofaro DG, Fernandes RA, Freitas Junior IF. Body composition variables as predictors of NAFLD by ultrasound in obese children and adolescents. BMC Pediatr. 2014;14:25.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 20]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
17.  Zhang X, Wan Y, Zhang S, Lu L, Chen Z, Liu H, Jiang X, Luo K, Cai W. Nonalcoholic fatty liver disease prevalence in urban school-aged children and adolescents from the Yangtze River delta region: a cross-sectional study. Asia Pac J Clin Nutr. 2015;24:281-288.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 10]  [Reference Citation Analysis (0)]
18.  Özhan B, Ersoy B, Özkol M, Kiremitci S, Ergin A. Waist to height ratio: a simple screening tool for nonalcoholic fatty liver disease in obese children. Turk J Pediatr. 2016;58:518-523.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 13]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
19.  Lin MS, Lin TH, Guo SE, Tsai MH, Chiang MS, Huang TJ, Chen MY. Waist-to-height ratio is a useful index for nonalcoholic fatty liver disease in children and adolescents: a secondary data analysis. BMC Public Health. 2017;17:851.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 33]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
20.  Dai H, Wang W, Chen R, Chen Z, Lu Y, Yuan H. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab (Lond). 2017;14:49.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 49]  [Cited by in F6Publishing: 70]  [Article Influence: 10.0]  [Reference Citation Analysis (0)]
21.  Parekh S, Anania FA. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology. 2007;132:2191-2207.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 237]  [Cited by in F6Publishing: 254]  [Article Influence: 14.9]  [Reference Citation Analysis (0)]
22.  Gaidos JK, Hillner BE, Sanyal AJ. A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis. Liver Int. 2008;28:650-658.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 44]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
23.  Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, Kahn R; Association for Weight Management and Obesity Prevention; NAASO; Obesity Society; American Society for Nutrition; American Diabetes Association. Waist circumference and cardiometabolic risk: a consensus statement from shaping America’s health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care. 2007;30:1647-1652.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 255]  [Cited by in F6Publishing: 244]  [Article Influence: 14.4]  [Reference Citation Analysis (0)]
24.  Chan DC, Watts GF, Barrett PH, Burke V. Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. QJM. 2003;96:441-447.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 152]  [Cited by in F6Publishing: 140]  [Article Influence: 6.7]  [Reference Citation Analysis (0)]
25.  Aller R, Izaola O, Ruiz-Rebollo L, Pacheco D, de Luis DA. Predictive factors of non-alcoholic steatohepatitis: relationship with metabolic syndrome. Nutr Hosp. 2015;31:2496-2502.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 5]  [Reference Citation Analysis (0)]
26.  World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva, World Health Organization, 2000.  Available from: http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Vasques ACJ, Priore ES, Rosado LEFPL, Francesch SCC. The use of anthropometric measures to assess visceral fat accumulation. Rev Nutr. 2010;23:107-118.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 21]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
28.  Pitanga FJ, Lessa I. Sensitivity and specificity of the conicity index as a coronary risk predictor among adults in Salvador. Brazil Rev Bras Epidemiol. 2004;7:259-269.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 29]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
29.  Haun DR, Pitanga FJ, Lessa I. Waist-height ratio compared to other anthropometric indicators of obesity as predictors of high coronary risk. Rev Assoc Med Bras (1992). 2009;55:705-711.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13:275-286.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1065]  [Cited by in F6Publishing: 1174]  [Article Influence: 97.8]  [Reference Citation Analysis (0)]
31.  Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr. 2005;56:303-307.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 542]  [Cited by in F6Publishing: 581]  [Article Influence: 32.3]  [Reference Citation Analysis (0)]
32.  Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 498]  [Cited by in F6Publishing: 532]  [Article Influence: 28.0]  [Reference Citation Analysis (0)]
33.  de Oliveira CC, Roriz AK, Ramos LB, Gomes Neto M. Indicators of Adiposity Predictors of Metabolic Syndrome in the Elderly. Ann Nutr Metab. 2017;70:9-15.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 28]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
34.  Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7:e39504.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 462]  [Cited by in F6Publishing: 653]  [Article Influence: 54.4]  [Reference Citation Analysis (0)]
35.  Thomas DM, Bredlau C, Bosy-Westphal A, Mueller M, Shen W, Gallagher D, Maeda Y, McDougall A, Peterson CM, Ravussin E. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity (Silver Spring). 2013;21:2264-2271.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 224]  [Cited by in F6Publishing: 318]  [Article Influence: 28.9]  [Reference Citation Analysis (0)]